# UPLIZNA

NDC: 75987-150
Generic name: Inebilizumab
Labeler / Manufacturer: Horizon Therapeutics USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20200611

FDA application: BLA761142

## Active ingredients

- INEBILIZUMAB: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"75987-150"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=75987-150
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=834db232-afb0-4dcf-93e0-009ce8245c20